The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility and utility of synthetic control arms derived from real-world data to support clinical development.
 
Jaclyn Paige Lyman
No Relationships to Disclose
 
Abigail Doucette
No Relationships to Disclose
 
Binbin Zheng-Lin
No Relationships to Disclose
 
Christopher R. Cabanski
No Relationships to Disclose
 
Molly A. Maloy
No Relationships to Disclose
 
Nicholas L. Bayless
Employment - Centivax
Consulting or Advisory Role - Centivax
 
Jingying Xu
Stock and Other Ownership Interests - Cellectis; Inovio Pharmaceuticals (I)
 
William Smith
No Relationships to Disclose
 
Joyson Joseph Karakunnel
Employment - Arcus Biosciences; Innate Pharma; Tizona Therapeutics, Inc.
Leadership - Innate Pharma; PrimeVax; Tizona Therapeutics, Inc.
Stock and Other Ownership Interests - Arcus Biosciences; AstraZeneca; Elucida Oncology; PrimeVax; Tizona Therapeutics, Inc.; Trishula Therapeutics
Patents, Royalties, Other Intellectual Property - Arcus Medimmune
Travel, Accommodations, Expenses - Arcus Biosciences; Innate Pharma; Tizona Therapeutics, Inc.
 
Justin P. Fairchild
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Ramy Ibrahim
Employment - Bit.bio; Milky way advisors
Leadership - Bluebird Bio; Lyell Immunopharma (Inst); Surface Oncology
Stock and Other Ownership Interests - Arcus Biosciences; Bluebird Bio; Harpoon therapeutics; Surface Oncology
Consulting or Advisory Role - Arcus Biosciences; Bit.bio; Georgiamune; Harpoon therapeutics; ImaginAb (Inst); IMV; Rheos Medicines
Travel, Accommodations, Expenses - Bit.bio; Innate Pharma
(OPTIONAL) Uncompensated Relationships - Omniox
 
Eileen Mary O'Reilly
Consulting or Advisory Role - Adicet Bio (I); Agios (I); Alnylam (I); AstraZeneca (I); Autem Medical (I); Bayer (I); BeiGene (I); Berry Genomics (I); Celgene; Center for Emerging & Neglected Diseases (CEND); CytomX Therapeutics; Eisai (I); Exelixis (I); Flatiron Health (I); Genentech/Roche (I); Genoscience Pharma (I); Helio Health (I); Incyte (I); Ipsen (I); Legend Biotech (I); Loxo; Merck; MINA THERAPEUTICS (I); Nerviano Medical Sciences (I); QED Therapeutics (I); Rafael Pharmaceuticals; RedHill Biopharma (I); Silenseed; Sillajen (I); SOBI; Surface Oncology (I); TheraBionic (I); twoXAR; Vector Health (I); Yiviva (I)
Research Funding - Arcus Ventures (Inst); AstraZeneca/MedImmune (Inst); BioNTech (Inst); Celgene (Inst); Genentech (Inst); Roche (Inst); Silenseed (Inst)
 
Robert H. Vonderheide
Patents, Royalties, Other Intellectual Property - Inventor on a licensed patient regarding cancer vaccine antigens; Receives royalties from Children’s Hospital Boston for a licensed research-only monoclonal antibody
 
Peter Edward Gabriel
Travel, Accommodations, Expenses - Varian Medical Systems; Varian Medical Systems